Shou-Zheng Wang (Shouzheng Wang)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Molecular cancer research : MCR

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Shou-Zheng Wang, Tongji Xie, Yan Li, Lei Guo, Jian-Ming Ying, Yan Wang, Xuezhi Hao, Xingyuan Wang, Junling Li, Puyuan Xing
Low TP53 variant allele frequency as a biomarker for anti-programmed death (ligand) 1 monotherapy in lung adenocarcinoma. Cancer (2023)
Yan Li, Ziyi Xu, Shou-Zheng Wang, Yi-Xiang Zhu, Di Ma, Yuxin Mu, Jian-Ming Ying, Jun-Ling Li, Pu-Yuan Xing
Disease monitoring of epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer patients treated with tyrosine kinase inhibitors via EGFR status in circulating tumor DNA. Thoracic cancer 13 (15) (2022)
Hong-Shuai Li, Shou-Zheng Wang, Hai-Yan Xu, Xiang Yan, Jin-Yao Zhang, Si-Yu Lei, Teng Li, Xue-Zhi Hao, Tao Zhang, Guang-Jian Yang, Li-Qiang Zhou, Peng Liu, Yu-Ying Wang, Xing-Sheng Hu, Pu-Yuan Xing, Yan Wang
Afatinib and Dacomitinib Efficacy, Safety, Progression Patterns, and Resistance Mechanisms in Patients with Non-Small Cell Lung Cancer Carrying Uncommon EGFR Mutations: A Comparative Cohort Study in China (AFANDA Study). Cancers 14 (21) (2022)
Tongji Xie, Zhenghao Liu, Yan Li, Shou-Zheng Wang, Yixin Zhai, Fei Teng, Xuezhi Hao, Yan Wang, Hongyu Wang, Xin Zhang, Xi Wu, Jianming Ying, Jun-Ling Li, Ye Zhang, Yuefei Deng, Pu-Yuan Xing
Evolutionary characteristics and immunological divergence of lung and brain metastasis lesions in NSCLC. Molecular cancer research : MCR (2022)